Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Deloitte
US Army
Argus Health
Daiichi Sankyo
QuintilesIMS
Baxter
Covington
Harvard Business School
Johnson and Johnson

Generated: August 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020886

« Back to Dashboard
NDA 020886 describes PANRETIN, which is a drug marketed by Eisai Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the PANRETIN profile page.

The generic ingredient in PANRETIN is alitretinoin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alitretinoin profile page.

Summary for NDA: 020886

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details

Pharmacology for NDA: 020886

Ingredient-typeRetinoids

Suppliers and Packaging for NDA: 020886

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PANRETIN
alitretinoin
GEL;TOPICAL 020886 NDA Eisai Inc. 62856-601 62856-601-22 60 g in 1 TUBE (62856-601-22)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrengthEQ 0.1% BASE
Approval Date:Feb 2, 1999TE:RLD:Yes
Patent:► SubscribePatent Expiration:Aug 3, 2016Product Flag?Substance Flag?Delist Request?
Patented Use:TOPICAL TREATMENT OF CUTANEOUS LESIONS IN PATIENTS WITH AIDS-RELATED KAPOSI'S SARCOMA

Expired Orange Book Patents for NDA: 020886

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Eisai Inc
PANRETIN
alitretinoin
GEL;TOPICAL020886-001Feb 2, 1999► Subscribe► Subscribe
Eisai Inc
PANRETIN
alitretinoin
GEL;TOPICAL020886-001Feb 2, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
McKinsey
AstraZeneca
US Army
Merck
Accenture
Chubb
Queensland Health
Argus Health
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot